Bristol-Myers Squibb(BMY) - 2024 Q3 - Quarterly Report
Bristol-Myers Squibb(BMY)2024-10-31 15:43UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 10-Q ___________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Route 206 & Province Line Road, Princeton, New Jersey 08543 (Address of principal executive ...